Provided by Tiger Trade Technology Pte. Ltd.

Mesoblast

17.00
-0.4300-2.47%
Post-market: 17.000.00000.00%19:42 EDT
Volume:164.74K
Turnover:2.80M
Market Cap:2.20B
PE:-23.10
High:17.11
Open:16.98
Low:16.81
Close:17.43
52wk High:21.50
52wk Low:12.66
Shares:129.69M
Float Shares:84.12M
Volume Ratio:0.68
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7359
EPS(LYR):-0.8457
ROE:-18.22%
ROA:-6.16%
PB:3.84
PE(LYR):-20.10

Loading ...

Mesoblast Says JPMorgan Ceases to be Substantial Holder

MT Newswires Live
·
Jun 12

Mesoblast Showcases Profitable Ryoncil Launch and Expanding Cell Therapy Pipeline in June 2026 CEO Presentation

TIPRANKS
·
Jun 10

Mesoblast Says Nearly $100 Million in Revenue Generated During First Year of Ryoncil Launch; Shares Fall 5%

MT Newswires Live
·
Apr 30

Press Release: Mesoblast Reports Ryoncil(R) Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million

Dow Jones
·
Apr 30

Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain

GlobeNewswire
·
Apr 29

Mesoblast Hits Phase 3 Recruitment Milestone in Chronic Back Pain Push

TIPRANKS
·
Apr 29

Mesoblast Details April Equity Issuance Moves and Director Share Purchases

TIPRANKS
·
Apr 17

Mesoblast Reports Lapse of 723,666 Options, Reducing Potential Dilution

TIPRANKS
·
Apr 16

Mesoblast Seeks ASX Quotation for 3.05 Million New Shares

TIPRANKS
·
Apr 16

Mesoblast Issues 815,000 Unquoted Options Under Employee Incentive Scheme

TIPRANKS
·
Apr 16

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galmed Pharmaceuticals (GLMD), Neurocrine (NBIX) and Mesoblast (MESO)

TIPRANKS
·
Apr 15

Sector Update: Health Care

MT Newswires Live
·
Apr 15

Mesoblast Acquires Exclusive License to Chimeric Antigen Receptor Platform; Shares Up 7%

MT Newswires Live
·
Apr 15

BRIEF-Mesoblast Acquires CAR Platform For Precision-Enhanced Cell Products

Reuters
·
Apr 15

Mesoblast Secures CAR Platform to Sharpen Targeting of Cell Therapies

TIPRANKS
·
Apr 15

Mesoblast Ltd - Obtains Worldwide Exclusive Rights to Car-MSC Ip From Mayo Clinic

THOMSON REUTERS
·
Apr 15

Mesoblast Ltd - to Incorporate Engineered Cars to Enhance Product Specificity

THOMSON REUTERS
·
Apr 15

Mesoblast Insider Makes Bold Multimillion-Dollar Move Into Company Stock

TIPRANKS
·
Apr 14

Top Mesoblast Insider Makes Massive New Bet on the Company’s Future

TIPRANKS
·
Apr 11

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION

GlobeNewswire
·
Apr 11